Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial
Mukerji SS, Pynnonen MA, Kim HM, Singer A, Tabor M
Published in Otolaryngology-Head and Neck Surgery
Methodology
Randomized double-blind placebo-controlled trial of oral Lactobacillus rhamnosus R0011 twice daily for 4 weeks with 8-week follow-up
Key Findings
Within-group SNOT-20 improvement at 4 weeks in the probiotic arm was not sustained and there were no significant between-group differences at 4 or 8 weeks
Conclusions
Oral L. rhamnosus R0011 did not improve quality of life versus placebo in chronic rhinosinusitis
Limitations
Single strain and dose, modest sample, short treatment period
Supplements Studied
Oral use of the probiotic strain Lactobacillus rhamnosus R0011 was not more effective than placebo.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.